Capital Markets: Equity (International Firms)
Greater China Region Guide 2025 : China
Band 5
Chambers Review
Cooley fields a well-respected team that covers US and Hong Kong listings, private placements, and secondary and follow-on offerings. Its team acts for issuers, sponsors and underwriters and is particularly renowned for handling IPOs in the tech, healthtech and life sciences sectors.
Hong Kong-based Will Cai heads the practice and is a key contact at the firm.
Work Highlights
- Cooley acted for Structure Therapeutics on its USD185.3 million IPO, including the full exercise of the underwriters’ option to purchase additional American depositary shares.
Strengths
Provided by Chambers
"Cooley are very resourceful and knowledgeable in dealing with listing rules and deal execution. The senior partners are very hands-on, providing insightful suggestions."
"The team are well connected in China's tech ecosystem and are willing to find solutions in difficult and complex situations."
"Cooley has a very strong Hong Kong capital market team. The lawyers have rich experience."
"Cooley are very resourceful and knowledgeable in dealing with listing rules and deal execution. The senior partners are very hands-on, providing insightful suggestions."
"The team are well connected in China's tech ecosystem and are willing to find solutions in difficult and complex situations."
"Cooley has a very strong Hong Kong capital market team. The lawyers have rich experience."